Company intelligence / Profile preview
Laboratoires Leurquin Mediolanum
Neuilly-sur-Marne, Île-de-France, Franceleurquin-mediolanum.fr ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Laboratoires Leurquin Mediolanum is a French pharmaceutical and nutraceutical company, a subsidiary of Mediolanum Farmaceutici SpA. It commercializes a range of prescription drugs and food supplements, with pipeline assets in oncology at Phase 2 and NDA/BLA stages through partnerships.
- Therapeutic areas
- NeurologyOncology
- Modalities
- Small moleculePeptidesProtein (enzymes)Vaccine (peptide-based cancer vaccine)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Soligenix Inc.Genovax SRLMediolanum Farmaceutici SpAActicor Biotech
Beyond the preview
Go deeper on Laboratoires Leurquin Mediolanum.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratoires Leurquin Mediolanum.